The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia.
Li X, Su Y, Hege K, Madlambayan G, Edwards H, Knight T, Polin L, Kushner J, Dzinic SH, White K, Yang J, Miller R, Wang G, Zhao L, Wang Y, Lin H, Taub JW, Ge Y.
Li X, et al. Among authors: wang g, wang y.
Haematologica. 2021 May 1;106(5):1262-1277. doi: 10.3324/haematol.2019.233445.
Haematologica. 2021.
PMID: 32165486
Free PMC article.